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Igh  restriction,  a  requirement  for  functional  identity  between  responding 
lymphocyte populations  at  the  Ig  heavy chain  allotype,  has  been  a  subject of 
intense  investigation  in  recent  years.  Igh-restricted  cell interactions  have  been 
shown  in  T  cell  responses to azobenzenearsonate  (ABA) 1 (1,  2),  PC (3,  4),  3- 
hydroxy-4-nitrophenyl (NP) (5),  larger antigens such as KLH (6), and SRBC (7, 
8), among others.  In the simple hapten systems, such interactions are commonly 
characterized  by the demonstration  of idiotypic structures on the responding T 
cells that are crossreactive with those found on antibodies of the same nominal 
specificity. Idiotype expression by T  cells, and the consequent functional restric- 
tions they dictate, are  more common with regulatory T  cells (Th and Ts) than 
effector T  cells, such as CTL,  further  suggesting a  role for such structures  in 
immunoregulation.  As such, these findings are indicative of a role for idiotype- 
anti-idiotype  interactions  in  the  maintenance  of immunologic  homeostasis and 
regulation  of responsiveness to  both self and  foreign antigens,  not just at  the 
level of antibody as  initially  proposed (9),  but potentially among  all  classes of 
lymphocytes. 
In  spite  of our  recognition  of the  role  of such  network  interactions  in  the 
mature animal, our understanding  of the means by which such tightly restricted 
interactions are established during ontogeny remains unclear. Why T  lymphocyte 
clones of a  given  idiotype come to dominate  the  response  in  one strain  while 
remaining  virtually  silent  in  others  is  a  subject  of considerable  controversy. 
Similarly, the means by which the mature T cell repertoire comes to be dominated 
by lymphocytes expressing idiotypic receptors that are complementary to those 
of the B cell repertoire and thus displays idiotypically restricted activity in T-T 
as well as T-B interactions  remains a puzzle.  Our laboratories have focused on 
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the T  cell repertoire, its generation, and functional restrictions for some years. 
Recently, we have been interested in how the mechanisms by which the compo- 
sition of T  cell regulatory networks and ultimately the composition of the T  cell 
repertoire as a  whole are established.  Specifically, we have examined the role 
played by idiotypes expressed on Ig-bearing B cells in suppressor T cell ontogeny. 
Chronic treatment of neonatal mice with a variety of Ig heavy chain-specific 
antibodies can result in suppression or virtual abrogation of antibody production 
(10-12),  apparently  by  functionally depleting  surface  Ig-expressing  B  cells. 
Treatment with most isotype-specific antibodies (anti-'y, anti-a, and anti-~) results 
in specific depletion of that isotype (13-15), but treatment with anti-~ causes the 
suppression  of all  isotypes, presumably due to  the presence of IgM  on  B  cell 
precursors of most  or all  isotypes (16-18).  The  strategy of anti-#  treatment, 
initially developed to study B cell ontogeny in chickens (19) and later in  mice 
(13,  20) has been successfully applied to the study of other questions in recent 
years.  We  have  used anti-u-treated mice to  examine the role  of Igh-encoded 
idiotypic determinants expressed by B cells during T  cell ontogeny. 
Anti-~ mice display virtually no (<2%) surface Ig  + lymphocytes in  spleen or 
lymph nodes, cannot generate responses to the B cell mitogen LPS, and have 
been reported to have undetectable or severely reduced levels of serum Ig (13, 
20-22).  Previously, we examined the influence of Ig upon the ultimate compo- 
sition of mature suppressor T  cell repertoires by comparing the genetic restric- 
tions of anti-u treated mice with those of normal and normal rabbit Ig-treated 
mice. In these studies the ABA-specific suppressor T  cell network was used. The 
well characterized interactions between idiotype positive suppressor/inducer cell 
(Ts,), anti-idiotype (Ts2), and idiotype positive effector cells (Ts3) are functionally 
restricted  by  the  idiotypes  characteristic  of  the  Igh  allotype  of  that  strain 
(reviewed in 23). Thus, C.AL-20 (Igh-1 a) Tsl or its soluble factor, TsF1, acts in 
syngeneic mice but not in the Igh congenics BALB/c (Igh-1 a) or CB-20 (Igh-lb). 
We found that  development of Ts  in  the virtual absence of B cells and  their 
products leads to profound changes in the T  cell idiotypic repertoire (24,  25). 
Anti-~  C.AL-20  Ts~  or  TsF~  fail  to  suppress  normal  C.AL-20  mice  but  are 
suppressive in syngeneic anti-u-treated C.AL-20 mice and, surprisingly, in normal 
Igh congenic BALB/c ABA-specific responses. A shift in the idiotypic composi- 
tion of the anti-~ C.AL-20 Ts repertoire was directly shown (26), accounting for 
these functional changes. The clear implication of these data was that B cells and 
Ig expressing the idiotypes characteristic of that strain's Igh allotype were acting 
to influence the composition of at least some components of the T  cell repertoire, 
in this case Ts. Such a hypothesis is consistent with studies carried out to examine 
Th repertoires developed in normal or Ig-deficient mice (27-31). 
Given  the  relationship  between  the  virtual  absence  of  Igh-encoded  gene 
products in the anti-# mice and the disruption of the normal T  cell repertoire 
that was observed, we postulated that the subsequent exposure of these T  cells 
to appropriate Igh-encoded determinants (Ig) would result in specific changes in 
the T  cell repertoire. The present study was carried out to test this hypothesis. 
In  these  experiments,  chronic  treatment of C.AL-20  mice  with  anti-ta  was 
discontinued at 6-8 wk of age and the gradual development of B cell maturity 
was followed. Simultaneously, the composition of the Ts repertoire was exam- 38  IMMUNOGLOBULIN AND  T  CELL  ID|OTYPE  NETWORKS 
ined.  We observed that the Ts repertoire underwent  a  precisely defined expan- 
sion, as shown  by the acquisition  of an additional  Ts restriction specificity. This 
idiotypically restricted  specificity is the same as that of Ts developed in  normal 
C.AL-20 mice. That is, previously anti-u-treated C.AL-20 mice retain the capacity 
to generate Ts that suppress CTL responses in BALB/c (Igh-l") mice, while they 
acquire  the  capacity  to  suppress  responses  in  normal  C.AL-20  (Igh-1 a)  mice 
within  2  wk of major increases in  the  levels of surface Ig  + B cells and serum  Ig. 
The  resulting,  functionally  chimeric  Ts  repertoire,  which  is  characterized  by 
expression of parallel idiotypically restricted Ts networks, is demonstrable for at 
least  13  wk.  The findings  provide further evidence of a  significant  role for  Ig- 
encoded  determinants  in  determining  the  composition of the  T  cell repertoire 
and, ultimately, the composition of immunologic networks as a  whole. 
Materials and  Methods 
Animals.  BALB/c (H-2  ~ and Igh-l") mice were obtained from Charles River Breeding 
Laboratories, Wilmington, MA. C.AL-20 (H-2  a and Igh-I d) and C.B-20 (H-2  a and Igh-I b) 
mice were obtained from breeding colonies maintained at Harvard Medical School. 
Anti-u C.AL-20 mice were prepared by treating newborns with  rabbit anti-mouse u 
chain antibodies,  as previously described  (24,  25).  Briefly, within  24  h  after birth  and 
three times weekly thereafter, C.AL-20 mice were injected intraperitonea[ly with  100 ul 
of concentrated antibody consisting of 700-1,000 ug of specific anti-mouse IgM activity. 
At 6 wk of age, chronic treatment ofanti-~ mice was discontinued and mice were thereafter 
bled at weekly intervals, until killed. 
All animals were maintained in accordance with guidelines of the Committee on Animals 
of the Harvard Medical School and those prepared by the Committee on Care and Use 
of Laboratory Animals of the Institute of Laboratory Animal Resources (NIH.publication 
No. 78-23, revised  1978). 
Preparation  of Antigen  and Antigen-Coupled  Cells.  A 40 mM solution of diazonium salt 
ofp-arsanilic acid ABA (Eastman Kodak Co., Rochester, NY) was activated and conjugated 
to single cell suspensions of erythrocyte-free syngeneic spleen cells (10 mM final concen- 
tration).  After washing  in  HBSS,  these  ABA-coupled spleen  ceils  (ABA-SC) cells were 
irradiated  (1,500  rad)  and  used  to prime for delayed-type hypersensitivity (DTH) and 
CTL responses (32).  TNP-conjugated spleen cells (TNP-SC) were prepared in a similar 
fashion by incubating normal spleen cells in a 10 mM trinitrobenzene sulfonic acid solution 
(TNBS) (Eastman Kodak Co.), pH 7.4, in a 37°C waterbath for 10 rain; they were washed 
extensively and irradiated as described above (33). 
Delayed Hypersensitivity.  Mice were primed by subcutaneous injection of 3 x  10 v ABA- 
coupled or TNP-coupled spleen cells.  6 d  later, they were challenged by injecting 25 ul 
of  10  mM  ABA  diazonium  salt  solution  or  10  mM  TNBS  solution  into  the  left hind 
footpad. 24 h later, footpad swelling was compared with the contralateral foot. 
Induction and Elicitation of CTL Responses.  To prime for the induction of ABA-specific 
CTL activity, groups of at least two normal, two normal rabbit Ig-treated, or two anti-u- 
treated mice were injected subcutaneously with  3  x  l0 T ABA-coupled spleen  cells.  7 d 
later  spleens  were  removed  from  each  group  of animals  and  single  cell  suspensions 
prepared for in vitro stimulation of CTL secondary responses. Briefly, 6 x  106 irradiated 
ABA-SC were cocultured  with  7  ×  106 responder spleen  cells  in  16-mm  Linbro tissue 
culture wells (Linbro Chemical Co., Hamden, CT) in a total volume of 2 ml/well. Culture 
nledium consisted of RPMI  1640 supplemented with  100 #g/ml of penicillin,  100 ~g/ml 
of streptomycin, 0.25 #g/ml of fungizone, 2 mM glutamine, 5 x  10 -'~ M 2-Me, and  10% 
preselected, heat-inactivated FCS.  Cultures were incubated for 5 d  in  5% CO2 at 37°C 
with saturated humidity. Chromium release assays were carried out using ABA-coupled 
or unhaptenated  ~Cr-labeled (:on  A-activated syngeneic blasts or P815  tumor cells  as 
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Preparation and Testing of Suppressor Factor (TsF~).  To induce Tsz, mice were injected 
intravenously with 5  ×  10 l  irradiated  ABA-SC (1,500  rad) and killed 7 d  later. A  snap 
freeze-thaw procedure (using spleen cell suspensions prepared from these mice) followed 
by high speed centrifugation (34) yielded cell-free lysates which were designated TsF~. 
To test the capacity of TsF~  to inhibit development of DTH or CTL responses, 2  x 
107 cell equivalents were administered intravenously on the day of immunization and for 
4  succeeding  days.  On  the  sixth  day  mice  were  footpad-challenged  to  assess  DTH 
responsiveness. 24 h later, footpad swelling was measured and the mice were killed to set 
up in  vitro, secondary CTL cultures, as described above. The genetic restrictions char- 
acteristic of TsF1 that we obtained from different groups of mice were evaluated by their 
capacity to induce suppression in syngeneic and Igh congenic, MHC identical mice. 
Fluorescence Analysis of  Surface Ig +  Cells.  The percentage of spleen or lymph node cells 
expressing cell surface (murine) Ig was determined by staining NH4Cl-treated spleen cells 
with FITC-conjugated rabbit anti-mouse Ig (recognizing murine #, 7, a, K, and ~, chains) 
or rabbit anti-goat Ig as a control.  After extensive washing, these cells were fixed and 
stored in a solution of 2% paraformaldehyde (Sigma Chemical Co., St.  Louis, MO) and 
1% BSA until analyzed. The number of surface Ig  + cells and their relative fluorescence 
intensity were determined  using a  FACS  II (Becton  Dickinson & Co.,  Mountain  View, 
CA) 5,000-10,000 cells were analyzed per sample. A duplicate preparation of each sample 
was independently stained and analyzed. 
Determination of Serum lg  Levels.  Total  serum  IgM  and  IgG concentrations  were 
measured by solid-phase RIA. Flexible, 96-well plates (Falcon 3911, Becton Dickinson & 
Co.,  Oxnard,  CA)  were  coated overnight with  affinity-purified goat anti-mouse  Ig (1 
mg/ml). The plates were washed with PBS and blocked with a PBS (1% BSA, 1% Tween 
20) solution for 2-4 h. After washing, duplicate serial dilutions of mouse sera or purified 
myeloma protein standards (MOPC  104E #,~; TEPC  183 #,K [Litton Bionetics, Kensing- 
ton, MD], mouse IgG, [Miles  Laboratories Inc., Naperville, ILl) were added for 6 h. The 
plates  were  washed  and  ~z5I-labeled  rabbit  anti-mouse  #  chain,  7  chains  or  K chain 
antibodies were added.  Sp act of these  reagents was determined for each labeling and 
ranged from 19-25 x  106 cpm/#g. The optimal dilution of radiolabeled Ig was determined 
for each reagent,  1-3 x  105 cpm/well being used. After overnight incubation at 4°C the 
wells were washed and counted. In each assay, the curve obtained with a myeloma protein 
of known  concentration  was  used  as a  standard.  The  sensitivity of the  assays allowed 
detection of IgM down to 30 ng/ml serum and IgG to 10-20 ng/ml. 
Results 
Recovery of the B Cell Repertoire  upon Stopping Chronic Anti-# Treatment.  Contin- 
uous treatment of mice with rabbit anti-mouse IgM antibodies beginning within 
24 h  of birth abrogates the development of functional B cell repertoires.  Anti-# 
mice contain no detectable mature B cells in spleen or lymph nodes as measured 
by the presence of surface Ig expression, no proliferative response to the  B cell 
mitogen LPS, and greatly reduced levels of serum Ig are detectable. 
It is known  that stopping anti-# treatment  in adulthood  ultimately allows the 
development of mature B cells and normal serum Ig levels (16).  To characterize 
the rate of appearance of mature B cell repertoires in such mice, chronic anti-# 
treatment was discontinued for 6-8-wk-old anti-# C.AL-20 mice. At the indicated 
times  thereafter,  mice  were  bled  and  in  some  cases  killed  to  determine  LPS 
responsiveness and the extent of surface Ig expression on spleen cells (Table I). 
It can be seen that during treatment and for up to several weeks thereafter anti- 
#  mice  have  no  demonstrable  surface  Ig  +  spleen  cells  and  cannot  respond  to 
LPS.  Beginning about the  fourth  to sixth week after discontinuing  anti-g treat- 
ment  (anti-#+  4  wk;  anti-u  +  6  wk),  significant  numbers  of  Ig-expressing 
lymphocytes can be found in the spleens of these animals. The number of B cells 40  IMMUNOGLOBUL|N  AND  T  CELL  IDIOTYPE NETWORKS 
TABLE  I 
Kinetics of Mature B Cell Development after Stopping Chronic Anti- 
Treatment 
Killed  LPS  Normal  Mice Tested*  sIg  ÷ cells  °  at:  response*  control u 
n  wk  %  %  % 
Normal C.AL-20 (>25)  0  100  29-42  100 
Anti-# C.AL-20 (>25)  0  <5  <2  <2 
Anti-# C.AL-20 (10)  1  <5  <2  <2 
Anti-# C.AL-20 (8)  2  <5  <2  <2 
Anti-# C.AL-20 (8)  3  <5  2-8  <2-23 
Anti-# C.AL-20 (14)  4  ND  <2-26  <2-66 
Anti-# C.AL-20 (6)  6  50-90  10-24  33-75 
Anti-# C.AL-20 (6)  7  86-118  18-31  50-100 
Anti-# C.AL-20 (4)  9  70-115  20-52  40-100 
* Spleen cells from normal or anti-#-treated C.AL-20 mice. 
* Relative capacity of spleen cells to generate  proliferative responses to LPS as 
described in Materials and Methods. Normal controls generated LPS responses 
of 70-166 X 103 cpm. 
Percentage  of spleen  cells positive  for  surface  immunoglobulin  by  FACS 
analysis using FITC-conjugated  rabbit  anti-mouse Ig.  Nonspecific staining 
with an  irrelevant  FITC-conjugated  antibody  (FITC-rabbit anti-goat  Ig) 
yielded 3-8% staining in the experiments shown and has been subtracted from 
the data presented. 
II Calculated percentage  of surface  Ig  + cells observed  in  normal  spleen cells 
stained that day. 
increases rapidly after this point, so that by 7-9 weeks B cells and LPS responses 
are usually comparable to those of control mice. 
A similar picture emerges from examination of total serum IgM and IgG levels 
(Fig.  1). Serum IgM is not detectable in anti-/, mice for some time after stopping 
treatment  (sensitivity  limit  of  assay,  30  ng  IgM/ml  mouse  serum).  Indeed, 
depending  upon the particular cohort of mice examined, serum IgM was some- 
times  not  detectable  for  20-25  d  after  stopping anti-ta  treatment.  By  4-6  wk 
after  stopping  anti-/*  treatment,  significant  amounts  of  IgM  were  detectable, 
rising rapidly from much less than  1% to 40-80%  of control values in untreated 
or normal rabbit Ig-treated mice. 
The development of serum IgG levels follows essentially the same pattern with 
one noteworthy exception. Although serum IgG levels in anti-# mice are consist- 
ently 2-3  logs lower than those in normal mice, IgG is not totally undetectable, 
averaging  10-40  ng/ml,  (0.01-0.1%  of normal  serum concentrations).  As with 
IgM, serum  IgG is  much  less  than  1%  of control  levels from the  first  2-3  wk 
after stopping anti-/s treatment.  Between  4  and  6  wk,  total  IgG concentrations 
rise to levels approaching those of normal controls. 
Total serum Ig levels measured in RIA using ~25I-labeled anti-K reagents were 
found  to confirm the pattern  of Ig expression presented above individually  for 
IgM and IgG isotypes (data not shown). 
If the  composition of the  functional  peripheral  T  cell repertoire is at least in 
part dependent  upon the nature of the idiotype expressing Ig present during T 
cell  ontogeny,  then  the  development  of B  cells in  adult,  anti-#  mice might  be HAYGLASS  ET  AL.  41 
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FIGURE  1.  Serum  Ig  levels in  chronically treated anti-/,  mice during and  after treatment. 
Mean serum IgM and IgG concentrations at various time points after stopping chronic anti-# 
treatment are expressed as (a) absolute concentrations or as (b) a percentage of normal control 
levels. The sensitivity limits of these solid-phase R1A are 0.75 ng/well murine IgM and 0.50 
ng/well IgG. 
expected to influence the composition of the T  cell repertoire. To examine this 
possibility, antigen-specific Tsl were induced in chronically treated anti-/, C.AL- 
20 mice and mice whose anti-/, treatment had been stopped for 3,  7, or 9  wk. 
The genetic restriction pattern of the cell-free iysate (TsFl) or the spleen cells 
(Ts~)  from  these mice was assessed  by examining their capacities to  suppress 
development of ABA-specific DTH  (Fig.  2).  The data shown, a compilation of 
four experiments, indicate a  major change in the Ts repertoire of these mice. 
We reported previously that TsF~  from anti-/~ C.AL-20  mice cannot suppress 
ABA-specific DTH,  IL-2  generation, or CTL  responses in  normal or normal 
rabbit  Ig-treated  C.AL-20  mice.  Anti-/~  C.AL-20  TsFI  (or  Tsl)  does  induce 
antigen-specific suppression of ABA responses in anti-/, C.AL-20 recipients and, 
interestingly, normal  Igh congenic BALB/c  mice (24).  The data presented in 
Fig. 2 confirm the capacity of TsF~ from anti-/* C.AL-20 mice to suppress DTH 
responses in BALB/c but not normal C.AL-20 mice. In addition, TsF~  induced 
3 wk after stopping anti-/, injections (anti-/, +  3 wk), a  time at which serum Ig 
levels  are  extremely  low,  was  found  to  display  the  same  functional  genetic 
restrictions as anti-/, C.AL-20 TsF~. However, TsF~ produced by C.AL-20 mice 
7-9  wk after stopping anti-# treatment, a  time by which serum Ig levels have 42  1MMUNOGLOBULIN  AND  T  CELL  IDIOTYPE  NETWORKS 
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FIGURE 2.  Altered genetic restrictions of TsFi produced by anti-u C.AL-20 mice at various 
times after stopping chronic anti-# treatment. DTH is expressed as a percentage of positive 
control footpad swelling by pooling data obtained in four separate experiments. Significant 
suppression (p < 0.05) of the capacity to mount DTH reactions is indicated (*). The magnitude 
of the positive controls ranged from 45-70 (+ 5-8) x  10  -~ ram. 
greatly  increased  (from  <<1%  to  40-80%  of control  levels),  shows an  Igh- 
restricted expansion of the Ts repertoire by its suppression of DTH responses in 
normal C.AL-20 mice. At the same time, the ability of TsF1 from these mice to 
suppress  development  of  DTH  in  BALB/c  mice  is  maintained.  The  DTH 
responses of M HC-identical  Igh-lb C.B-20 mice are not affected by treatment 
with any of these TsF~ preparations  (data not shown), indicating  that a  specific 
(Igh-l<restricted)  acquisition  rather  than  a  total  loss  of  Igh  restriction  has 
occurred in these mice. 
These findings were confirmed and extended by assessing the capacity of TsF~ 
to inhibit establishment of CTL responses (Fig. 3). Normal C.AL-20 and BALB/c 
mice were primed  with  ABA-coupled spleen  cells, treated  with TsF~  from the 
donors  indicated,  challenged  for  DTH,  then  used to  measure  secondary anti- 
ABA CTL responses. It is apparent that while TsF~ from anti-# C.AL-20 +  3 wk 
mice suppressed  DTH and  CTL  responses in  BALB/c mice,  it had  no  impact 
upon the ability of normal  C.AL-20 mice to generate  DTH or CTL responses. 
Thus,  it exhibits the same characteristic  restrictions as anti-# C.AL-20 TsF~.  In 
contrast, TsF~ produced by anti-# C.AL-20 +  7 wk mice displays the capacity to 
suppress  BALB/c  responses  and  has  acquired  the  ability  to  suppress  normal 
C.AL-20 DTH and CTL responses as well. 
Expansion  of the  functional  Ts  repertoire  is  antigen-specific  (TNP-specific 
responses are not affected, data not shown) and  Igh-ld-restricted,  as shown by 
the failure of these TsF1 to suppress CTL or DTH responses of C.B-20 (Igh-I b) 
mice (data not shown). 
Correlation between Serum Ig Expression and Expansion of the Ts Repertoire.  The 
relationship  between the development of normal  C.AL-20 B cell repertoires  in 
anti-# mice and the acquisition of normal C.AL-20 TSl repertoires was strength- 
ened by the series of experiments presented in Table II. While it was consistently 
found that TsF1 prepared _<3 wk after stopping anti-# treatment (a time at which HAYGLASS  ET  AL  43 
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FIGURE 3.  Genetic restrictions of T sF1 from anti-# C.AL-20 mice generated 3 or 7 wk after 
stopping chronic anti-# treatment. Normal C.AL-20 and normal BALB/c mice were primed 
with  3 x  107 ABA-coupled syngeneic spleen cells and treated with TsFt produced by anti-# 
C.AL-20 mice +  3  wk (O), anti-# C.AL-20 +  7 wk (A), or were left untreated (Q). Their 
capacity to  mount  CTL  and  DTH  responses  was assessed  as described in  Materials and 
Methods. 
TABLE  II 
Correlation between Appearance  of Surface Ig-Expressing Spleen 
Cells and Igh-Restricted Expansion of the Ts Repertoire 
Killed  slg  ÷  Exp.  TsFl donor  at:  cells* 
Suppression* 
C.AL-20  BALB/c 
wk  %  % 
1  Anti-# C.AL-20  5  <2  0  30-45 
2  Anti-# C.AL-20  5  6  0-9  45-82 
3  Anti-# C.AL-20  5  37  41-80  40-97 
4  Anti-# C.AL-20  5  23  90-93  79-84 
* Percentage of spleen  cells  from  TsF~  donors  that  stain  with  FITC- 
conjugated rabbit anti-mouse Ig. Data are shown  after subtraction of 
nonspecific staining with rabbit anti-goat Ig (2-6% in these assays). 
* Suppression of ABA-specific CTL responses in normal C.AL-20 and 
BALB/c mice relative to positive controls upon treatment with TsFI 
from the donors indicated. 
significant B  cell expansion  had  not  yet occurred)  was functionally identical to 
that  of anti-#  mice  still  under  treatment,  and  that  TsF~  prepared  from  anti-# 
C.AL-20  mice  >7  wk after stopping chronic  anti-#  treatment  consistently sup- 
pressed  ABA-specific responses  in  both  BALB/c  and  C.AL-20  mice,  the  func- 
tional restrictions of TsF~ prepared  5  wk after stopping anti-# injections yielded 44  IMMUNOGLOBULIN  AND  T  CELL  IDIOTYPE  NETWORKS 
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FIGURE  4.  Prolonged  maintenance of dual suppressor T  cell repertoires  in anti-/~ C.AL-20 
mice after stopping anti-/~ treatment.  Anti-~ C.AL-20 mice and those whose anti-/~ treatment 
had been stopped 10 or 20 wk previously were primed with 3 X 107 ABA-coupled  spleen cells 
for CTL responses, and were treated with normal (Igh-ld-restricted) C.AL-20 TsFt (I-1), normal 
(Igh-la-restricted) BALB/c TsFi (O) or were left untreated (0). Their ability to generate CTL 
responses was then assessed as described in Materials and Methods. 
variable results.  In some experiments anti-is C.AL-20 +  5 wk TsFt displayed Igh 
restrictions characteristic of anti-is mice (Table II, Experiment !  and 2), while in 
others an Igh-restricted expansion of the Ts repertoire had occurred (Experiment 
3 and 4), as shown by its capacity to suppress CTL responses in both Igh-l" and 
Igh-1 d haplotype mice. Similar findings were obtained with the capacity of these 
TsF~  to suppress the development of DTH responses (data not shown).  To our 
great interest, analysis of the Ts~  donor spleens in these experiments revealed a 
strict association  between  the presence of mature  B  cells and  the expansion  of 
the Ts~ repertoire. That is, TsF~ obtained from anti-Is +  5 wk mice with significant 
reconstitution of the B cell repertoire displayed a parallel expansion of the (id+) 
TSl  repertoire,  while cohorts of mice where  the  B  cell repertoire had  not yet 
recovered showed restrictions in the Ts~ repertoire characteristic of anti-Is mice 
still under treatment. 
Prolonged  Maintenance  of  Functionally  Chimeric Suppressor  T  Cell Reper- 
toires.  In light of our findings that stopping anti-# treatment of C.AL-20 mice 
leads to the development of dual Ts~ repertoires, it was of interest to determine 
(a)  if a  similar  expansion  of the suppressor cell repertoire is demonstrable  for 
Ts2 and Ts3 cells after stopping anti-Is treatment and (b) if the existence of dual 
Ts repertoires is a transient state. 
In these experiments, the ability of Igh-P-restricted or Igh-l'Lrestricted TsF~ 
to suppress CTL responses in anti-Is C.AL-20 mice and anti-Is C.AL-20 +  10 wk 
or  +  20  wk  mice  was  assessed.  Anti-Is  C.AL-20  mice  were  primed  for  ABA- 
specific CTL responses  10 and  20  wk  after stopping chronic anti-Is treatment, 
and the capacity of normal BALB/c or normal C.AL-20 TsF~ to induce suppres- 
sion in these mice was determined. Unlike either normal or anti-Is-treated mice, 
anti-Is C.AL-20 +  10 wk or +  20 wk mice are receptive to TsF~  obtained from 
both  Igh-I ~ and  Igh-1 d donors (Fig.  4).  This is  reminiscent of what was  found 
for  the  Ts~  repertoires  in  anti-Is  +  7  or  +  9  wk  mice,  which  exhibited  dual 
suppressor cell repertoires at the TSl level. Igh-lb-restricted TsF~ failed to induce HAYGLASS  ET  AL.  45 
suppression (data not shown), indicating that the Ts2,3 repertoires in these mice, 
though activated by TsF~  from either Igh-l" or Igh-1 d mice, display two distinct 
Igh restrictions rather than a nonspecific loss of Igh restriction. 
It is of particular interest to note that the maintenance of these dual, idiotyp- 
ically restricted Ts repertoires is long lived, persisting for at least 13-15 wk. 
Discussion 
We have previously examined the generation of Igh genetic restrictions be- 
tween lymphocytes and the resulting establishment of idiotype-based networks 
by comparing the composition of Ts repertoires in normal and anti-#-treated (B 
cell-deficient) mice. This report represents a different approach to the study of 
the role of Igh-linked determinants in T cell development. It has been established 
(13, 16) that stopping anti-/z treatment of adult mice results in a gradual decrease 
in circulating rabbit anti-mouse ~ antibodies, followed by maturation of pre-B 
cells,  and  ultimately, generation  of functional  B  cell  repertoires and  normal 
levels of serum Ig. 
In the present report we have investigated the consequences of this natural 
reconstitution of the B cell repertoire upon the composition of the Ts repertoire. 
Mature B cell activity, virtually absent in mice under chronic anti-/~ treatment, 
recovers substantially  within  4-6  wk  after stopping  anti-#  treatment.  Igh-re- 
stricted expansion of the Ts repertoire consistently follows within 2 wk of major 
increases of splenic B cells and serum Ig concentrations. At the same time, the 
already established  Ts  repertoire  that  is  characteristic  of anti-/~  mice  under 
treatment is fully retained. Thus, by 7 wk after stopping anti-/t treatment, the 
Ts repertoire of anti-# C.AL-20 mice is functionally expanded. 
TsF1  from these mice suppress DTH and CTL responses in Igh-1 a (BALB/c) 
and Igh-1 ~ (C.AE-20), but not control Igh-1 b (C.B.20) mice. This change in the 
Ts~ repertoire is reflected in a similar fashion in the Ts2 and Ts~ repertoires of 
these mice. The acquisition of a complete, parallel, Igh-restricted suppressor cell 
network  in  these  mice  is  governed  by  Igh  restrictions  characteristic  of the 
expressed Ts repertoire in normal (Ig-containing) C.AL-20 mice. Thus, the Ts 
repertoire  characteristic  of anti-#  C.AL-20  mice  under  chronic  treatment  is 
maintained and a  new,  previously silent Ts repertoire,  complementary to  the 
developing B cell repertoire, is expanded. 
It would be tempting to conclude that the association between the development 
of B  cell  maturity in  previously anti-/~  treated  C.AL-20  mice and  the strictly 
limited expansion of the Ts repertoire that follows 2 wk later is causally related. 
There are indeed several relevant points that would provide support for such an 
interpretation:  (a) The inflection point in  the development of B cell maturity 
comes ~5 wk after stopping anti-/a treatment. While some cohorts of mice develop 
a functional B cell repertoire somewhat more rapidly and others more slowly, it 
is striking that those mice in which the B cell repertoire is significantly reconsti- 
tuted within 5 wk display a corresponding expansion of the Ts repertoire, while 
those mice in  which substantial  B cell activity has not yet emerged display no 
detectable change in Ts restrictions; (b) total serum Ig levels in individual cohorts 
of mice consistently revealed sharp increases  10-20  d  before Tsj  induction in 
those mice that displayed chimeric Ts repertoires. Mice in which such increases 46  IMMUNOGLOBULIN  AND  T  CELL  IDIOTYPE  NETWORKS 
were not observed did  not have any detectable changes in the composition of 
the Ts~ repertoire (data not shown). 
It  is  interesting  that  the  present  experimental design  mimics,  in  a  natural 
fashion, the previously described experimental manipulations in which transfer 
of peripheral  T  cells (Igh-l"-derived, Thy-l.2  +) to an irradiated  Igh congenic 
environment (Igh- 1  b, Thy- 1.1 ) leads to "reeducation" of the donor Ts repertoire. 
TsF1  produced by cells parked in an Igh congenic (Igh-1 b) environment for 12 
d then showed the capacity to suppress responses in Igh-1 b, as well as Igh-l" but 
not control Igh-1" recipients (35). 
A prominent difference between this and the present report is that the former 
involves T  cell enrichment, adoptive transfer to an Igh congenic environment, 
and  other procedures to ensure that the resultant TsF~  is  truly derived from 
donor T  cells and not residual host T  cells. In the present report, T  cells were 
left  in  situ  to  be  naturally  exposed  to  significant  concentrations of novel  Ig 
determinants with a minimum of experimental manipulation. Results from both 
approaches show that exposure of the T  cell repertoire to normal concentrations 
of murine Ig is associated with Igh-restricted expansion of the Ts repertoire. In 
both cases, this expansion is functionally limited to T cells responsive to idiotypes 
characteristic of that particular Igh allotype, and not others. We postulate, but 
have not yet shown that these functionally chimeric Ts repertoires (Igh-la-/Igh  - 
1  d-restricted) are composed of distinct Igh- 1  X-restricted and Igh- 1  d-restricted Ts 
populations. 
The finding that a dual functional repertoire is maintained for at least 13 wk 
is of considerable interest. It suggests that once established, the Ts repertoire is 
remarkably stable. Given the appropriate environmental stimuli one may expand 
previously silent T  cell clones, thereby adding to the expressed repertoire, but it 
appears that components of the T  cell repertoire expanded soon after birth may 
remain stable and functional indefinitely. 
This result displays some similarities with  observations made for the TNP- 
specific Th  repertoire.  Normal  and anti-u-treated  BALB/c  mice both  display 
functional  but  idiotypically distinct  TNP-specific  Th  repertoires  (36).  It  was 
recently determined that mice that are chronically anti-u-treated for the first 3- 
4  wk  of life and  then  stopped  contain  TNP-specific Th  repertoires  that  are 
unchanged (at 9 wk of age) from those of anti-u mice still under treatment (37). 
These results were interpreted to  suggest that  Th  repertoires are established 
early in  life and  are thereafter stable,  a  finding that  concurs with  the above 
demonstrated stability of the ABA-specific Ts repertoire of anti-u mice. 
However, the two systems differ in that the Igh-restricted expansion of the Ts 
repertoire of anti-u mice that is observed after spontaneous development of the 
C.AL-20 B cell repertoire was not observed for the TNP-specific Th repertoire 
in anti-u BALB/c mice. This failure of the Th repertoire to expand was observed 
up to  9  wk of age (i.e.,  4-5  wk after stopping anti-u treatment).  The time at 
which  the  B  cell  repertoire  was  reconstituted  in  these  mice  remains  to  be 
established. It is possible that the apparent discrepancy is a reflection of different 
rates of B cell reconstitution in  the two strains and that the TNP-specific Th 
repertoire some 7-10 wk after stopping anti-u treatment would also be idiotypi- 
cally expanded. Alternatively, it is possible that Th and Ts repertoires display HAYGLASS ET  AL.  47 
different degrees of flexibility, with the helper cell repertoire fixed early in life 
and the suppressor cell repertoire responsive to changing environmental stimuli, 
such as idiotype, throughout the lifetime of the animal. 
Summary 
B  cell-deficient (anti-~-treated)  mice have proven  to be a  valuable tool with 
which to examine the influence of Ig idiotypic determinants upon the develop- 
ment of the Ts repertoire.  We have previously reported that ABA-specific Ts 
repertoires  matured in  normal and  Ig-deficient environments differ from one 
another in their composition, and consequently, their functionally expressed Igh 
restrictions. 
The present report characterizes the impact of natural development of mature 
B cell activity upon the composition of the Ts repertoire. 
After stopping anti-~ treatment of C.AL-20 mice, ABA-specific Ts repertoires 
undergo  a  defined expansion  shown  by  their  acquisition  of an  additional  Ts 
network  that  displays  Igh  restrictions  characteristic  of normal  C.AL-20  mice. 
This  Igh-la-restricted  repertoire  can  be  readily  shown  within  2  wk  of major 
increases in surface Ig spleen cells and total serum Ig levels in these mice. At the 
same time, the original Ts restriction specificity (Igh-la-restricted) generated in 
the Ig-deficient environment of anti-~ C.AL-20 mice, is not lost for at least 20 
wk.  The  resulting dual  Ts  repertoire,  characterized  by expression  of parallel, 
idiotypically restricted Ts networks, is demonstrable for at least  13  wk. These 
findings favor an important role for Ig determinants in determining the makeup 
of the T cell repertoire, and ultimately, the composition of immunologic networks 
as a whole. 
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